InvestorsHub Logo
Followers 1
Posts 5
Boards Moderated 0
Alias Born 02/22/2014

Re: None

Monday, 12/08/2014 10:54:27 AM

Monday, December 08, 2014 10:54:27 AM

Post# of 909
Any idea what happens with the $1.0+ shareholder bonus on achieving sales goal of tetizold TR-701 (supposed to kick in 2017) with Merck acquisition of cubist. Does the timetable accelerate for original shareholders of trius?